Annual Total Liabilities
$9.56 M
-$3.86 M-28.77%
December 31, 2023
Summary
- As of February 24, 2025, RGLS annual total liabilities is $9.56 million, with the most recent change of -$3.86 million (-28.77%) on December 31, 2023.
- During the last 3 years, RGLS annual total liabilities has fallen by -$2.02 million (-17.40%).
- RGLS annual total liabilities is now -88.67% below its all-time high of $84.38 million, reached on December 31, 2011.
Performance
RGLS Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$6.96 M
+$1.02 M+17.18%
September 30, 2024
Summary
- As of February 24, 2025, RGLS quarterly total liabilities is $6.96 million, with the most recent change of +$1.02 million (+17.18%) on September 30, 2024.
- Over the past year, RGLS quarterly total liabilities has stayed the same.
- RGLS quarterly total liabilities is now -92.43% below its all-time high of $91.87 million, reached on September 30, 2012.
Performance
RGLS Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
RGLS Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -28.8% | 0.0% |
| 3 y3 years | -17.4% | -41.7% |
| 5 y5 years | -71.7% | -67.7% |
RGLS Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -29.1% | at low | -48.4% | +17.2% |
| 5 y | 5-year | -56.7% | at low | -68.5% | +17.2% |
| alltime | all time | -88.7% | at low | -92.4% | +17.2% |
Regulus Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $6.96 M(+17.2%) |
| Jun 2024 | - | $5.94 M(-9.3%) |
| Mar 2024 | - | $6.55 M(-31.5%) |
| Dec 2023 | $9.56 M(-28.8%) | $9.56 M(+0.8%) |
| Sep 2023 | - | $9.49 M(-1.7%) |
| Jun 2023 | - | $9.65 M(-7.4%) |
| Mar 2023 | - | $10.42 M(-22.4%) |
| Dec 2022 | $13.43 M(-0.5%) | $13.43 M(+7.8%) |
| Sep 2022 | - | $12.46 M(+4.4%) |
| Jun 2022 | - | $11.93 M(+1.6%) |
| Mar 2022 | - | $11.74 M(-13.0%) |
| Dec 2021 | $13.50 M(+16.6%) | $13.50 M(-3.8%) |
| Sep 2021 | - | $14.03 M(+10.6%) |
| Jun 2021 | - | $12.69 M(-0.3%) |
| Mar 2021 | - | $12.73 M(+9.9%) |
| Dec 2020 | $11.58 M(-47.5%) | $11.58 M(-40.9%) |
| Sep 2020 | - | $19.59 M(-7.6%) |
| Jun 2020 | - | $21.20 M(+5.4%) |
| Mar 2020 | - | $20.10 M(-8.9%) |
| Dec 2019 | $22.07 M(-34.7%) | $22.07 M(+2.4%) |
| Sep 2019 | - | $21.55 M(+2.9%) |
| Jun 2019 | - | $20.95 M(-19.3%) |
| Mar 2019 | - | $25.95 M(-23.2%) |
| Dec 2018 | $33.78 M | $33.78 M(+1.8%) |
| Sep 2018 | - | $33.19 M(-14.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2018 | - | $38.74 M(-1.2%) |
| Mar 2018 | - | $39.20 M(-8.0%) |
| Dec 2017 | $42.59 M(-4.5%) | $42.59 M(+0.8%) |
| Sep 2017 | - | $42.27 M(+1.0%) |
| Jun 2017 | - | $41.87 M(+1.0%) |
| Mar 2017 | - | $41.45 M(-7.0%) |
| Dec 2016 | $44.59 M(+162.2%) | $44.59 M(+2.3%) |
| Sep 2016 | - | $43.58 M(+5.1%) |
| Jun 2016 | - | $41.48 M(+98.4%) |
| Mar 2016 | - | $20.91 M(+23.0%) |
| Dec 2015 | $17.00 M(-56.9%) | $17.00 M(-3.3%) |
| Sep 2015 | - | $17.59 M(-0.3%) |
| Jun 2015 | - | $17.64 M(-2.1%) |
| Mar 2015 | - | $18.02 M(-54.3%) |
| Dec 2014 | $39.47 M(+33.3%) | $39.47 M(+31.8%) |
| Sep 2014 | - | $29.93 M(-6.0%) |
| Jun 2014 | - | $31.84 M(+0.1%) |
| Mar 2014 | - | $31.82 M(+7.5%) |
| Dec 2013 | $29.61 M(-28.5%) | $29.61 M(-18.1%) |
| Sep 2013 | - | $36.14 M(-16.3%) |
| Jun 2013 | - | $43.20 M(+4.9%) |
| Mar 2013 | - | $41.16 M(-0.6%) |
| Dec 2012 | $41.42 M(-50.9%) | $41.42 M(-54.9%) |
| Sep 2012 | - | $91.87 M(+199.2%) |
| Jun 2012 | - | $30.70 M(-63.6%) |
| Dec 2011 | $84.38 M | $84.38 M |
FAQ
- What is Regulus Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Regulus Therapeutics?
- What is Regulus Therapeutics annual total liabilities year-on-year change?
- What is Regulus Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Regulus Therapeutics?
- What is Regulus Therapeutics quarterly total liabilities year-on-year change?
What is Regulus Therapeutics annual total liabilities?
The current annual total liabilities of RGLS is $9.56 M
What is the all time high annual total liabilities for Regulus Therapeutics?
Regulus Therapeutics all-time high annual total liabilities is $84.38 M
What is Regulus Therapeutics annual total liabilities year-on-year change?
Over the past year, RGLS annual total liabilities has changed by -$3.86 M (-28.77%)
What is Regulus Therapeutics quarterly total liabilities?
The current quarterly total liabilities of RGLS is $6.96 M
What is the all time high quarterly total liabilities for Regulus Therapeutics?
Regulus Therapeutics all-time high quarterly total liabilities is $91.87 M
What is Regulus Therapeutics quarterly total liabilities year-on-year change?
Over the past year, RGLS quarterly total liabilities has changed by $0.00 (0.00%)